Inactive Instrument

Press Releases Kitov Pharma Ltd TEL AVIV STOCK EXCHANGE

Equities

IL0007650166

Press Releases

Unlock all the news: Be the first to know and act before the market!

Purple Biotech : Immediate Report	05/06	PU
Purple Biotech Announces Positive Late-Breaking Interim Randomized Phase 2 Data at ASCO 2024 Demonstrating CM24 Improved Overall Survival and other Efficacy Endpoints in Pancreatic Cancer	01/06	AQ
Purple Biotech Reports First Quarter 2024 Financial Results	21/05	AQ
Purple Biotech to Present New Data On its Oncology Drug NT219 at AACR 2024	28/03	AQ
Purple Biotech : Immediate Report	07/03	PU
6K:Fourth Quarter and Full-Year 2023 Financial Results	05/03	PU
Purple Biotech Reports Fourth Quarter and Full-Year 2023 Financial Results	05/03	AQ
Purple Biotech Presents Data of its Phase 1 Head & Neck Cancer of NT219 in combination with Cetuximab at ESMO TAT Congress 2024	27/02	AQ
Purple Biotech Convenes a Head & Neck Cancer Scientific Advisory Board in Preparation for NT219 Phase 2 Trial	13/02	AQ
Purple Biotech Completes Patient Enrollment in Phase 2 Pancreatic Cancer Trial	14/12	AQ
Papillary Thyroid Cancer Pipeline, Clinical Trials Studies, Emerging Drugs, Mergers and Acquisition, Licensing, Agreements & Collaborations, and Latest News 2023 (Updated)	30/11	AQ
Purple Biotech Reports Third Quarter 2023 Financial Results	21/11	AQ
Purple Biotech Fortifies NT219 Patent Protection	02/11	AQ
Purple Biotech : Other Report or Announcement	01/23/01	PU
Purple Biotech : Immediate report on other matter	31/23/31	PU
Purple Biotech : Other Report or Announcement	19/23/19	PU
Purple Biotech : Form of Securities Purchase Agreement - Form 6-K	19/23/19	PU
Purple Biotech Announces $5 Million Registered Direct Offering	17/23/17	AQ
Purple Biotech : Immediate Report	17/23/17	PU
Purple Biotech : Immediate Report	13/23/13	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Kitov Pharma Ltd TEL AVIV STOCK EXCHANGE

Equities

IL0007650166

Press Releases

Filters